These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8498904)

  • 1. Focusing on membranes.
    von Sengbusch G; Bowry S; Vienken J
    Artif Organs; 1993 Apr; 17(4):244-53. PubMed ID: 8498904
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of dialysis membrane on serum beta 2-microglobulin (beta 2M) in chronic haemodialysis patients.
    Farrell J; Bastani B
    Nephrol Dial Transplant; 1997 Apr; 12(4):856. PubMed ID: 9141041
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes.
    Floege J; Koch KM
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S52-6. PubMed ID: 7923985
    [No Abstract]   [Full Text] [Related]  

  • 4. High-efficiency dialysis with PMMA dialyzers: treatment dose delivery and long-term results.
    David S; Cambi V
    Contrib Nephrol; 1999; 125():96-110. PubMed ID: 9895434
    [No Abstract]   [Full Text] [Related]  

  • 5. Dialysis membranes inhibit synthesis and release of beta 2-microglobulin in lymphocyte culture.
    Campistol JM; Molina R; Rodriguez R; Mirapeix E; Muñoz-Gomez J; Revert L
    Nephron; 1991; 59(4):691-2. PubMed ID: 1809274
    [No Abstract]   [Full Text] [Related]  

  • 6. Can the nephrologist prevent dialysis-related amyloidosis?
    Zingraff J; Drüeke T
    Am J Kidney Dis; 1991 Jul; 18(1):1-11. PubMed ID: 2063840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialysis-related amyloidosis and high-flux membranes.
    Floege J; Smeby L
    Contrib Nephrol; 1992; 96():124-37. PubMed ID: 1740047
    [No Abstract]   [Full Text] [Related]  

  • 8. Biocompatibility study on cuprophane and polysulphone dialysers.
    Taraba I; Polner K; Makó J
    Nephrol Dial Transplant; 1991; 6 Suppl 3():22-5. PubMed ID: 1775261
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative and qualitative assessment and clinical meaning of molecules removed with BK membranes.
    Buoncristiani U; Galli F; Benedetti S; Errico R; Beninati S; Ghibelli L; Floridi A; Canestrari F
    Contrib Nephrol; 1999; 125():133-58. PubMed ID: 9895437
    [No Abstract]   [Full Text] [Related]  

  • 10. [Beta 2-microglobulin and dialysis-related amyloidosis].
    Gejyo F
    Rinsho Byori; 2001 Mar; 49(3):244-8. PubMed ID: 11307323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Amyloidosis of the dialysis patient].
    van Ypersele de Strihou C
    Bull Mem Acad R Med Belg; 1988; 143(10-12):456-65; discussion 465-7. PubMed ID: 3077074
    [No Abstract]   [Full Text] [Related]  

  • 12. Amyloidosis and its relationship to different dialysers.
    van Ypersele de Strihou C; Floege J; Jadoul M; Koch KM
    Nephrol Dial Transplant; 1994; 9 Suppl 2():156-61. PubMed ID: 8065608
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta 2-microglobulin amyloidosis.
    Saito A
    Nephrol Dial Transplant; 1994; 9 Suppl 2():116-9. PubMed ID: 8065602
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical experience with PMMA membrane.
    Albertazzi A; Bonomini M
    Contrib Nephrol; 1999; 125():213-21. PubMed ID: 9895443
    [No Abstract]   [Full Text] [Related]  

  • 15. Factors affecting beta 2-microglobulin plasma concentration during hemodialysis.
    Martin-Malo A; Mallol J; Castillo D; Barrio V; Burdiel LG; Perez R; Aljama P
    Int J Artif Organs; 1989 Aug; 12(8):509-14. PubMed ID: 2681000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dialysate buffer on serum beta-2-microglobulin levels in chronic hemodialysis.
    Küchle C; Lang SM; Schiffl H
    Nephron; 1998; 79(1):99-100. PubMed ID: 9609469
    [No Abstract]   [Full Text] [Related]  

  • 17. Biocompatibility of haemodialysis membranes.
    van Berlo A; Ellens DJ
    Adv Exp Med Biol; 1988; 238():341-58. PubMed ID: 3074642
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of beta2-microglobulin and c-fos mRNA: is there an influence of high- or low-flux dialyzer membranes?
    Haufe CC; Eismann U; Deppisch RM; Stein G
    Kidney Int Suppl; 2001 Feb; 78():S177-81. PubMed ID: 11169006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta 2-Microglobulin amyloidosis: effect of ESRF treatment modality and dialysis membrane type.
    Van Ypersele de Strihou C
    Nephrol Dial Transplant; 1996; 11 Suppl 2():147-9. PubMed ID: 8804017
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnostic and therapeutic aspects of dialysis-related amyloidosis].
    Kopeć J
    Przegl Lek; 2006; 63(7):567-72. PubMed ID: 17203811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.